Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

36.13
-0.0500-0.14%
Post-market: 36.150.0200+0.06%16:49 EDT
Volume:871.68K
Turnover:31.48M
Market Cap:2.12B
PE:-53.34
High:36.80
Open:36.35
Low:35.60
Close:36.18
52wk High:52.91
52wk Low:15.27
Shares:58.67M
Float Shares:53.55M
Volume Ratio:0.41
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6773
EPS(LYR):-0.3410
ROE:-18.21%
ROA:-3.15%
PB:8.27
PE(LYR):-105.95

Loading ...

Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed?

Simply Wall St.
·
Aug 12

Analysts’ Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)

TIPRANKS
·
Aug 04

Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report

Simply Wall St.
·
Aug 01

Axogen is Maintained at Market Outperform by Citizens

Dow Jones
·
Jul 30

Vericel Beats Q2 Revenue Estimates, Boosts Annual Outlook

Reuters
·
Jul 30

AxoGen, Inc. : H.c. Wainwright Raises Target Price to $53 from $50

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

AxoGen price target raised to $55 from $50 at Jefferies

TIPRANKS
·
Jul 30

AxoGen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

GUIDANCE: (AXGN) Axogen Expects 2026 Revenue At Least $279M, vs. FactSet Est of $270.9M

MT Newswires Live
·
Jul 29

AxoGen Q2 Revenue Beats Estimates on Breast Procedure Growth

Reuters
·
Jul 29

Shares of AxoGen Down 3.1% Premarket After Q2 Results

THOMSON REUTERS
·
Jul 29

Axogen Q2 Adj. EPS $0.12 Misses $0.13 Estimate, Sales $69.731M Beat $67.098M Estimate

Benzinga Earnings
·
Jul 29

AxoGen Q2 Revenue USD 69.7 Million Vs. IBES Estimate USD 67.1 Million

Reuters
·
Jul 29

AxoGen, Inc. Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 29

AxoGen Q2 Adjusted Ebitda USD 8.4 Million

THOMSON REUTERS
·
Jul 29

AxoGen Q2 Gross Margin 72.7%

THOMSON REUTERS
·
Jul 29

Axogen, Inc. Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 29

Does NZS Capital’s ‘Optionality’ Stake and Coverage Momentum Change The Bull Case For Axogen (AXGN)?

Simply Wall St.
·
Jul 24

Earning Preview: AxoGen this quarter’s revenue is expected to increase by 27.40%, and institutional views are bullish

Earnings Agent
·
Jul 23